Pim 1 kinase inhibitor ETP-45299 suppresses cellular proliferation and synergizes with PI3K inhibition

被引:48
作者
Blanco-Aparicio, Carmen [1 ]
Garcia Collazo, Ana Maria [1 ]
Oyarzabal, Julen [1 ]
Leal, Juan F. [1 ]
Isabel Albaran, Maria [1 ]
Ramos Lima, Francisco [1 ]
Pequeno, Belen [1 ]
Ajenjo, Nuria [1 ]
Becerra, Mercedes [1 ]
Alfonso, Patricia [1 ]
Isabel Reymundo, Maria [1 ]
Palacios, Irene [1 ]
Mateos, Genoveva [1 ]
Quinones, Helena [1 ]
Corrioneio, Ana [1 ]
Carnero, Amancio [1 ]
Pevarello, Paolo [1 ]
Rodriguez Lopez, Ana [1 ]
Fominaya, Jesus [1 ]
Pastor, Joaquin [1 ]
Bischoff, James R. [1 ]
机构
[1] Spanish Natl Canc Res Ctr CNIO, Expt Therapeut Programme, Madrid 28029, Spain
关键词
Pim; 1; Kinase inhibitors; PI3K; AML; PUTATIVE ONCOGENE PIM-1; SERINE/THREONINE KINASES; STRUCTURAL BASIS; C-MYC; LEUKEMIA; PROTEIN; GROWTH; CANCER; PHOSPHORYLATION; ACTIVATION;
D O I
10.1016/j.canlet.2010.09.016
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
The serine/threonine Pim 1 kinase is an oncogene whose expression is deregulated in several human cancers Overexpression of Pim 1 facilitates cell cycle progression and suppresses apoptosis Hence pharmacologic inhibitors of Pim 1 are of therapeutic interest for cancer ETP-45299 is a potent and selective inhibitor of Pun 1 that inhibits the phosphorylation of Bad and 4EBP1 in cells and suppresses the proliferation of several non-solid and solid human tumor cell lines The combination of the PI3K inhibitor GDC-0941 with ETP-45299 was strongly synergistic in MV-4-11 AML cells indicating that the combination of selective Pim kinase inhibitors and PI3K inhibitor could have clinical benefit (C) 2010 Elsevier Ireland Ltd All rights reserved
引用
收藏
页码:145 / 153
页数:9
相关论文
共 39 条
[1]
Pim-1 kinase promotes inactivation of the pro-apoptotic bad protein by phosphorylating it on the Ser112 gatekeeper site [J].
Aho, TLT ;
Sandholm, J ;
Peltola, KJ ;
Mankonen, HP ;
Lilly, M ;
Koskinen, PJ .
FEBS LETTERS, 2004, 571 (1-3) :43-49
[2]
THE HUMAN PROTOONCOGENE PRODUCT P33PIM IS EXPRESSED DURING FETAL HEMATOPOIESIS AND IN DIVERSE LEUKEMIAS [J].
AMSON, R ;
SIGAUX, F ;
PRZEDBORSKI, S ;
FLANDRIN, G ;
GIVOL, D ;
TELERMAN, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (22) :8857-8861
[3]
Novel benzylidene-thiazolidine-2,4-diones inhibit Pim protein kinase activity and induce cell cycle arrest in leukemia and prostate cancer cells [J].
Beharry, Zanna ;
Zemskova, Marina ;
Mahajan, Sandeep ;
Zhang, Fengxue ;
Ma, Jian ;
Xia, Zuping ;
Lilly, Michael ;
Smith, Charles D. ;
Kraft, Andrew S. .
MOLECULAR CANCER THERAPEUTICS, 2009, 8 (06) :1473-1483
[4]
PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers [J].
Brault, Laurent ;
Gasser, Christelle ;
Bracher, Franz ;
Huber, Kilian ;
Knapp, Stefan ;
Schwaller, Juerg .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (06) :1004-1015
[5]
Structural basis of inhibitor specificity of the human protooncogene proviral insertion site in Moloney murine leukemia virus (PIM-1) kinase [J].
Bullock, AN ;
Debreczeni, JÉ ;
Fedorov, OY ;
Nelson, A ;
Marsden, BD ;
Knapp, S .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (24) :7604-7614
[6]
Structure and substrate specificity of the Pim-1 kinase [J].
Bullock, AN ;
Debreczeni, J ;
Amos, AL ;
Knapp, S ;
Turk, BE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (50) :41675-41682
[7]
Hypoxia-Mediated Up-Regulation of Pim-1 Contributes to Solid Tumor Formation [J].
Chen, Jian ;
Kobayashi, Masanobu ;
Darmanin, Stephanie ;
Qiao, Yi ;
Gully, Christopher ;
Zhao, Ruiying ;
Kondo, Satoshi ;
Wang, Hua ;
Wang, Huamin ;
Yeung, Sai-Ching Jim ;
Lee, Mong-Hong .
AMERICAN JOURNAL OF PATHOLOGY, 2009, 175 (01) :400-411
[8]
Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells [J].
Chen, Lisa S. ;
Redkar, Sanjeev ;
Bearss, David ;
Wierda, William G. ;
Gandhi, Varsha .
BLOOD, 2009, 114 (19) :4150-4157
[9]
Pim family kinases enhance tumor growth of prostate cancer cells [J].
Chen, WW ;
Chan, DC ;
Donald, C ;
Lilly, MB ;
Kraft, AS .
MOLECULAR CANCER RESEARCH, 2005, 3 (08) :443-451
[10]
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099